326 related articles for article (PubMed ID: 33684574)
1. 5-Aminolevulinic Acid-Shedding Light on Where to Focus.
Dadario NB; Khatri D; Reichman N; Nwagwu CD; D'Amico RS
World Neurosurg; 2021 Jun; 150():9-16. PubMed ID: 33684574
[TBL] [Abstract][Full Text] [Related]
2. What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
Hadjipanayis CG; Widhalm G; Stummer W
Neurosurgery; 2015 Nov; 77(5):663-73. PubMed ID: 26308630
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO; Berger MS
J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
[TBL] [Abstract][Full Text] [Related]
4. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review.
Broekx S; Weyns F; De Vleeschouwer S
Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study.
Schupper AJ; Baron RB; Cheung W; Rodriguez J; Kalkanis SN; Chohan MO; Andersen BJ; Chamoun R; Nahed BV; Zacharia BE; Kennedy J; Moulding HD; Zucker L; Chicoine MR; Olson JJ; Jensen RL; Sherman JH; Zhang X; Price G; Fowkes M; Germano IM; Carter BS; Hadjipanayis CG; Yong RL
J Neurosurg; 2022 Jun; 136(6):1525-1534. PubMed ID: 34624862
[TBL] [Abstract][Full Text] [Related]
6. Optimization of high-grade glioma resection using 5-ALA fluorescence-guided surgery: A literature review and practical recommendations from the neuro-oncology club of the French society of neurosurgery.
Picart T; Berhouma M; Dumot C; Pallud J; Metellus P; Armoiry X; Guyotat J
Neurochirurgie; 2019 Aug; 65(4):164-177. PubMed ID: 31125558
[TBL] [Abstract][Full Text] [Related]
7. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
Haider SA; Lim S; Kalkanis SN; Lee IY
J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
[TBL] [Abstract][Full Text] [Related]
9. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-ALA dose on resection of glioblastoma.
Michael AP; Watson VL; Ryan D; Delfino KR; Bekker SV; Cozzens JW
J Neurooncol; 2019 Feb; 141(3):523-531. PubMed ID: 30644009
[TBL] [Abstract][Full Text] [Related]
11. Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma.
Liu Z; Mela A; Argenziano MG; Banu MA; Furnari J; Kotidis C; Sperring CP; Humala N; Mahajan A; Bruce JN; Canoll P; Sims PA
J Neurosurg; 2024 Apr; 140(4):968-978. PubMed ID: 37773782
[TBL] [Abstract][Full Text] [Related]
12. Optimization of novel exoscopic blue light filter during fluorescence-guided resection of Glioblastoma.
Witten AJ; Ben-Shalom N; Ellis JA; Boockvar JA; D'Amico RS
J Neurooncol; 2023 Feb; 161(3):617-623. PubMed ID: 36745272
[TBL] [Abstract][Full Text] [Related]
13. Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.
Picart T; Pallud J; Berthiller J; Dumot C; Berhouma M; Ducray F; Armoiry X; Margier J; Guerre P; Varlet P; Meyronet D; Metellus P; Guyotat J;
J Neurosurg; 2024 Apr; 140(4):987-1000. PubMed ID: 37856381
[TBL] [Abstract][Full Text] [Related]
14. Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery-review of the literature.
Suero Molina E; Schipmann S; Stummer W
Neurosurg Rev; 2019 Jun; 42(2):197-208. PubMed ID: 28921173
[TBL] [Abstract][Full Text] [Related]
15. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
[TBL] [Abstract][Full Text] [Related]
16. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
[TBL] [Abstract][Full Text] [Related]
17. Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas--with special regard to high-grade tumors.
Cornelius JF; Slotty PJ; Kamp MA; Schneiderhan TM; Steiger HJ; El-Khatib M
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):481-90. PubMed ID: 25117928
[TBL] [Abstract][Full Text] [Related]
18. Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome.
Barbagallo GMV; Certo F; Di Gregorio S; Maione M; Garozzo M; Peschillo S; Altieri R
Neurosurg Focus; 2021 Jan; 50(1):E20. PubMed ID: 33386001
[TBL] [Abstract][Full Text] [Related]
19. Established and emerging uses of 5-ALA in the brain: an overview.
Díez Valle R; Hadjipanayis CG; Stummer W
J Neurooncol; 2019 Feb; 141(3):487-494. PubMed ID: 30607705
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up.
Strickland BA; Wedemeyer M; Ruzevick J; Micko A; Shahrestani S; Daneshmand S; Shiroishi MS; Hwang DH; Attenello F; Chen T; Zada G
J Neurosurg; 2022 Nov; 137(5):1378-1386. PubMed ID: 35303704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
